284 related articles for article (PubMed ID: 17085372)
1. Is HRT justified for symptom management in women at higher risk of developing breast cancer?
Rippy L; Marsden J
Climacteric; 2006 Dec; 9(6):404-15. PubMed ID: 17085372
[TBL] [Abstract][Full Text] [Related]
2. [Hormone replacement therapy and cancer of the breast. 1. Does replacement therapy increase the risk of cancer of the breast?].
Ayres de Campos D; Barros H; Martinez de Oliveira J
Acta Med Port; 1997 Oct; 10(10):697-703. PubMed ID: 9477595
[TBL] [Abstract][Full Text] [Related]
3. Hormone therapy and breast cancer risk.
Foidart JM; Desreux J; Pintiaux A; Gompel A
Climacteric; 2007 Oct; 10 Suppl 2():54-61. PubMed ID: 17882674
[TBL] [Abstract][Full Text] [Related]
4. Hormone replacement therapy in women with a history of breast cancer.
Ylikorkala O; Metsä-Heikkilä M
Gynecol Endocrinol; 2002 Dec; 16(6):469-78. PubMed ID: 12626034
[TBL] [Abstract][Full Text] [Related]
5. [Controversy between estrogen replacement therapy and risk of breast cancer in menopause].
Zárate A
Gac Med Mex; 2002; 138(1):105-7. PubMed ID: 11885123
[TBL] [Abstract][Full Text] [Related]
6. Increased risk of recurrence after hormone replacement therapy in breast cancer survivors.
Holmberg L; Iversen OE; Rudenstam CM; Hammar M; Kumpulainen E; Jaskiewicz J; Jassem J; Dobaczewska D; Fjosne HE; Peralta O; Arriagada R; Holmqvist M; Maenpaa J;
J Natl Cancer Inst; 2008 Apr; 100(7):475-82. PubMed ID: 18364505
[TBL] [Abstract][Full Text] [Related]
7. Hormone replacement therapy in breast cancer survivors.
Xydakis AM; Sakkas EG; Mastorakos G
Ann N Y Acad Sci; 2006 Dec; 1092():349-60. PubMed ID: 17308160
[TBL] [Abstract][Full Text] [Related]
8. Hormone replacement therapy after breast cancer: 10 year follow up of the Stockholm randomised trial.
Fahlén M; Fornander T; Johansson H; Johansson U; Rutqvist LE; Wilking N; von Schoultz E
Eur J Cancer; 2013 Jan; 49(1):52-9. PubMed ID: 22892060
[TBL] [Abstract][Full Text] [Related]
9. [Last word on hormone replacement and breast cancer?].
Rookus MA; van Leeuwen FE; Hamerlynck JV
Ned Tijdschr Geneeskd; 1998 Jan; 142(3):111-3. PubMed ID: 9557006
[TBL] [Abstract][Full Text] [Related]
10. [Hormone replacement therapy and cancer].
Bjørge T; Tropé C
Tidsskr Nor Laegeforen; 1997 Jun; 117(15):2201-7. PubMed ID: 9235712
[TBL] [Abstract][Full Text] [Related]
11. [Estrogen replacement therapy and breast cancer].
Bakken K; Alsaker E; Eggen AE; Lund E
Tidsskr Nor Laegeforen; 2005 Feb; 125(3):282-5. PubMed ID: 15702147
[TBL] [Abstract][Full Text] [Related]
12. The controversy of hormone-replacement therapy in breast cancer survivors.
Snyder GM; Sielsch EC; Reville B
Oncol Nurs Forum; 1998 May; 25(4):699-706; quiz 707-8. PubMed ID: 9599353
[TBL] [Abstract][Full Text] [Related]
13. Hormone replacement therapy in breast cancer patients and survivors.
Del Priore G; Hatami M
Curr Womens Health Rep; 2003 Apr; 3(2):165-9. PubMed ID: 12628087
[TBL] [Abstract][Full Text] [Related]
14. Breast cancer risk in the WHI study: the problem of obesity.
Kuhl H
Maturitas; 2005 May; 51(1):83-97. PubMed ID: 15883113
[TBL] [Abstract][Full Text] [Related]
15. Cancer surveillance during HRT.
Palacios S
Int J Fertil Menopausal Stud; 1994; 39 Suppl 2():93-8. PubMed ID: 7874192
[TBL] [Abstract][Full Text] [Related]
16. [Hormone replacement therapy in breast cancer survivors: the Israeli Society for Clinical Oncology and Radiotherapy policy letter].
Siegelmann-Danieli N; Ron I; Kaufman B; Uzieli B; Karminsky N; Inbar M;
Harefuah; 2004 Oct; 143(10):753-6, 764. PubMed ID: 15521355
[TBL] [Abstract][Full Text] [Related]
17. Effect modification by catalase genotype suggests a role for oxidative stress in the association of hormone replacement therapy with postmenopausal breast cancer risk.
Quick SK; Shields PG; Nie J; Platek ME; McCann SE; Hutson AD; Trevisan M; Vito D; Modali R; Lehman TA; Seddon M; Edge SB; Marian C; Muti P; Freudenheim JL
Cancer Epidemiol Biomarkers Prev; 2008 May; 17(5):1082-7. PubMed ID: 18483329
[TBL] [Abstract][Full Text] [Related]
18. [Hormone replacement therapy in breast cancer survivors: the Israeli Society for Clinical Oncology and Radiotherapy policy letter].
Siegelmann-Danieli N; Ron I; Kaufman B; Uzieli B; Karminsky N; Inbar M;
Harefuah; 2002 Nov; 141(11):994-6, 1008. PubMed ID: 12476637
[TBL] [Abstract][Full Text] [Related]
19. Hormonal exposures and breast cancer in a sample of women with systemic lupus erythematosus.
Bernatsky S; Clarke A; Ramsey-Goldman R; Joseph L; Boivin JF; Rajan R; Moore AD; Leung MH; Allen A; Gordon C
Rheumatology (Oxford); 2004 Sep; 43(9):1178-81. PubMed ID: 15226516
[TBL] [Abstract][Full Text] [Related]
20. Cancer issues.
Marsden J; Sturdee D
Best Pract Res Clin Obstet Gynaecol; 2009 Feb; 23(1):87-107. PubMed ID: 19036643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
